Group 1: Financial Performance - The company achieved a revenue of 10,660.68 million yuan in the first half of 2025, representing a year-on-year increase of 1.44% [4] - The operating profit for the same period was -178.63 million yuan, a decline of 184.72% due to decreased gross margins on certain products [4] - The revenue from nuclear radiation monitoring equipment increased by 19.50% year-on-year, reaching 7,832.70 million yuan [6] Group 2: Strategic Initiatives - The company is focusing on upgrading production processes through smart manufacturing, aiming to shorten delivery cycles for core products [3] - A nationwide after-sales service network has been established to enhance customer engagement and support [4] - The company is actively pursuing international expansion, although it currently has no overseas revenue [10] Group 3: Research and Development - The R&D team comprises over 20% of the total workforce, with more than 30 members holding advanced degrees, supporting continuous innovation [4] - The company is collaborating with various research institutions to enhance technology iteration speed and product development [5] - The company is developing a drone-based nuclear and biochemical monitoring system, addressing new safety demands in the low-altitude economy [8] Group 4: Market Opportunities - The company is leveraging opportunities in emergency management equipment upgrades, particularly in the civil nuclear and biochemical protection market [3] - There is a focus on modular design advantages in nuclear and biochemical safety equipment to strengthen core competitiveness in military applications [6] - The company is exploring the commercialization of multi-sensor data fusion technology patents approved in the first half of 2025 [5]

与投资者同行 为价值共筑——天津辖区上市公司2025年投资者网上集体接待日暨半年报业绩说明会9月 11日在全景网举行。捷强装备（300875）（300875）董事长兼总经理潘淇靖表示，公司核化一体智能化 监测系统等产品已应用于相关客户。公司严格按照有关法律、法规和公司章程的要求，及时履行信息披 露义务。 ...